UNCY - Unicycive Therapeutics Inc
IEX Last Trade
0.3317
-0.011 -3.346%
Share volume: 1,183,547
Last Updated: Fri 30 Aug 2024 09:59:25 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.34
-0.01
-3.24%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-12 | 2022-08-15 | 2022-11-14 | 2023-03-31 | 2023-05-16 | 2023-08-14 | 2023-11-14 | 2024-03-28 | |
| Cash flow financing | 0.000 | 0.000 | 0.000 | -471.000 K | 27.797 M | 0.000 | -51.000 K | -205.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -2.957 M | -3.047 M | -3.563 M | -6.084 M | -3.920 M | -5.502 M | -4.422 M | -4.439 M | |
| Net income | -3.537 M | -3.636 M | -5.557 M | -5.328 M | -14.767 M | -4.441 M | -4.405 M | -6.931 M | |
| Depreciation | 39.000 K | 40.000 K | 40.000 K | 42.000 K | 45.000 K | 78.000 K | 79.000 K | 82.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -2.000 K | 0.000 | 0.000 | 0.000 | 0.000 | -12.000 K | 0.000 | 0.000 | |
| Net Borrowings | -15.195 M | -18.105 M | -9.768 M | -2.489 M | -25.193 M | -20.993 M | -17.703 M | -12.606 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -2.000 K | 0.000 | 0.000 | 0.000 | 0.000 | -12.000 K | 0.000 | 0.000 | |
| Cash Change | 13.620 M | 16.579 M | 7.010 M | 455.000 K | 24.332 M | 18.818 M | 14.345 M | 9.701 M |